{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:56:50Z","timestamp":1788267410277,"version":"build-2803163510"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Kidney disease is a common complication in heart transplant recipients and requires a comprehensive and personalized approach. The interplay between preexisting kidney disease, perioperative factors, immunosuppression, and cardiovascular complications makes the management of kidney dysfunction challenging in these patients. The objective of this expert consensus was to look for agreements for the management of chronic kidney disease in heart transplant recipients. A panel of Spanish cardiologists and nephrologists with expertise in heart and kidney transplantation reviewed the evidence related to the current management of chronic kidney disease in heart transplant recipients and consensus statements were developed using a 2-round Delphi methodology. Consensus statements were proposed covering key topics, including the identification and management of kidney disease in heart transplant recipients and the indications for kidney transplantation. These statements provide additional expert guidance for the management of kidney disease in patients undergoing heart transplantation where published clinical evidence is scarce.<\/jats:p>","DOI":"10.1097\/tp.0000000000005302","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:26Z","timestamp":1738886426000},"page":"e431-e445","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Management of Kidney Disease in Heart Transplant Patients: A National Delphi Survey-based Consensus Expert Paper"],"prefix":"10.1097","volume":"109","author":[{"given":"Mar\u00eda Dolores","family":"Garc\u00eda-Cos\u00edo Carmena","sequence":"first","affiliation":[{"name":"Cardiology Department, Hospital Universitario 12 de Octubre, Imas12, CIBERCV, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Farrero","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Cl\u00ednic, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Blasco Peir\u00f3","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Crespo","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital del Mar, Hospital del Mar Research Institute, National Network for Kidney Research RICORS2040 RD21\/0005\/0022, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Delgado Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitario 12 de Octubre, Imas12, CIBERCV, Universidad Complutense de Madrid, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"D\u00edaz Molina","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitario Central de Asturias, Oviedo, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantino","family":"Fern\u00e1ndez Rivera","sequence":"additional","affiliation":[{"name":"Nephrology Department, Complexo Hospitalario Universitario A Coru\u00f1a, A Coru\u00f1a, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris Paula","family":"Garrido Bravo","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Cl\u00ednico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"L\u00f3pez Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Regional Universitario de M\u00e1laga, National Network for Kidney Research RICORS2040 RD21\/0005\/0012, Instituto Biom\u00e9dico de Investigaci\u00f3n de M\u00e1laga (IBIMA), Universidad de M\u00e1laga, M\u00e1laga, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Melilli","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Universitario de Bellvitge, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Mirabet P\u00e9rez","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital de la Santa Creu i Sant Pau, CIBERCV, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Lourdes","family":"P\u00e9rez Tamaj\u00f3n","sequence":"additional","affiliation":[{"name":"Nephrology Department, Complejo Hospitalario Universitario de Canarias, Santa Cruz de Tenerife, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Rangel Sousa","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitario Virgen del Roc\u00edo, Sevilla, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Rodrigo","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL, Santander, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Mar\u00eda","family":"Cruzado","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Universitario de Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), University of Barcelona, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo","family":"Hern\u00e1ndez Marrero","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Universitario de Canarias, National Network for Kidney Research RICORS2040 RD21\/0005\/0012; Instituto de Tecnolog\u00edas Biom\u00e9dicas, Universidad de La Laguna, Santa Cruz de Tenerife, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the Spanish Society of Transplantation, the Spanish Society of Nephrology, and the Spanish Society of Cardiology (SET-SEC-SEN)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"R1-20250821","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ccc.2018.08.009","article-title":"Renal complications following lung transplantation and heart transplantation.","volume":"35","author":"Puttarajappa","year":"2019","journal-title":"Crit Care Clin"},{"key":"R2-20250821","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.healun.2014.08.004","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report - 2014; focus theme: retransplantation.","volume":"33","author":"Yusen","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R3-20250821","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archinte.168.9.987","article-title":"Long-term prognosis of acute kidney injury after acute myocardial infarction.","volume":"168","author":"Parikh","year":"2008","journal-title":"Arch Intern Med"},{"key":"R4-20250821","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ndt\/gfr275","article-title":"Effect of mean arterial pressure, haemoglobin and blood transfusion during cardiopulmonary bypass on post-operative acute kidney injury.","volume":"27","author":"Haase","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R5-20250821","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0009-9236(03)00168-1","article-title":"Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus.","volume":"74","author":"Hesselink","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"R6-20250821","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.healun.2005.02.002","article-title":"Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.","volume":"24","author":"Eisen","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R7-20250821","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1053\/j.ajkd.2014.12.020","article-title":"Bk virus nephropathy in heart transplant recipients.","volume":"65","author":"Joseph","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R8-20250821","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients.","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R9-20250821","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7861\/clinmedicine.10-4-358","article-title":"A review of grading systems for evidence-based guidelines produced by medical specialties.","volume":"10","author":"Baker","year":"2010","journal-title":"Clin Med (Lond)"},{"key":"R10-20250821","article-title":"A guideline developer\u2019s handbook."},{"key":"R11-20250821","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research.","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"key":"R12-20250821","article-title":"The RAND\/UCLA Appropriateness Method User\u2019s Manual [cited 2024 April 22].","author":"Fitch"},{"key":"R13-20250821","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","article-title":"Research guidelines for the Delphi survey technique.","volume":"32","author":"Hasson","year":"2000","journal-title":"J Adv Nurs"},{"key":"R14-20250821","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1111\/ajt.16512","article-title":"Consensus conference on heart-kidney transplantation.","volume":"21","author":"Kobashigawa","year":"2021","journal-title":"Am J Transplant"},{"key":"R15-20250821","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14797\/mdcvj.1139","article-title":"Combined heart-kidney transplantation: Indications, outcomes, and controversies.","volume":"18","author":"Ahsan","year":"2022","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"R16-20250821","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update.","volume":"35","author":"Mehra","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R17-20250821","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.healun.2016.05.028","article-title":"Pre-orthotopic heart transplant estimated glomerular filtration rate predicts post-transplant mortality and renal outcomes: an analysis of the UNOS database.","volume":"35","author":"Habib","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R18-20250821","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jtcvs.2013.09.017","article-title":"Combined heart-kidney transplant improves post-transplant survival compared with isolated heart transplant in recipients with reduced glomerular filtration rate: analysis of 593 combined heart-kidney transplants from the United Network Organ Sharing Database.","volume":"147","author":"Karamlou","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R19-20250821","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association.","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"R20-20250821","first-page":"302","article-title":"Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease.","volume":"34","author":"Gorostidi","year":"2014","journal-title":"Nefrologia"},{"key":"R21-20250821","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/TP.0b013e3181cd4abb","article-title":"The role of kidney biopsy in heart transplant candidates with kidney disease.","volume":"89","author":"Labban","year":"2010","journal-title":"Transplantation"},{"key":"R22-20250821","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41581-018-0080-9","article-title":"Estimated GFR: time for a critical appraisal.","volume":"15","author":"Porrini","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"R23-20250821","first-page":"1597","article-title":"Iohexol plasma clearance simplified by dried blood spot testing.","volume":"33","author":"Luis-Lima","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"R24-20250821","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/ckj\/sfz012","article-title":"Impact of errors of creatinine and cystatin C equations in the selection of living kidney donors.","volume":"12","author":"Gonz\u00e1lez-Rinne","year":"2019","journal-title":"Clin Kidney J"},{"key":"R25-20250821","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/j.ajkd.2014.04.010","article-title":"Measuring GFR: a systematic review.","volume":"64","author":"Soveri","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R26-20250821","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ckj\/sfw070","article-title":"Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: How to measure glomerular filtration rate with iohexol?","volume":"9","author":"Delanaye","year":"2016","journal-title":"Clin Kidney J"},{"key":"R27-20250821","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ckj\/sfw071","article-title":"Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: Why to measure glomerular filtration rate with iohexol?","volume":"9","author":"Delanaye","year":"2016","journal-title":"Clin Kidney J"},{"key":"R28-20250821","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/TP.0000000000004662","article-title":"The enigma of heart-kidney transplantation.","volume":"107","author":"Barten","year":"2023","journal-title":"Transplantation"},{"key":"R29-20250821","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.healun.2019.01.206","article-title":"Long-term changes in kidney function after left ventricular assist device implant: an analysis of the STS intermacs database.","volume":"38","author":"Franz","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R30-20250821","first-page":"1111","article-title":"Impella support and acute kidney injury during high-risk percutaneous coronary intervention: the Global cVAD Renal Protection Study.","volume":"95","author":"Flaherty","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"R31-20250821","doi-asserted-by":"crossref","first-page":"252","DOI":"10.34067\/KID.0000000000000365","article-title":"High rate of kidney graft failure after simultaneous heart-kidney transplantation.","volume":"5","author":"Okumura","year":"2024","journal-title":"Kidney360"},{"key":"R32-20250821","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1097\/TP.0000000000004661","article-title":"Simultaneous heart-kidney transplant with planned delayed implantation of the kidney graft after ex vivo perfusion.","volume":"107","author":"Lutz","year":"2023","journal-title":"Transplantation"},{"key":"R33-20250821","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1111\/ajt.15361","article-title":"Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from six months after heart transplantation: the randomized MANDELA study.","volume":"19","author":"Barten","year":"2019","journal-title":"Am J Transplant"},{"key":"R34-20250821","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.healun.2011.12.010","article-title":"Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate.","volume":"31","author":"Arora","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R35-20250821","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/TP.0000000000001945","article-title":"Optimizing the safety profile of everolimus by delayed initiation in de novo heart transplant recipients: results of the prospective randomized study EVERHEART.","volume":"102","author":"Potena","year":"2018","journal-title":"Transplantation"},{"key":"R36-20250821","doi-asserted-by":"crossref","first-page":"e13054","DOI":"10.1111\/ctr.13054","article-title":"Conversion from calcineurin inhibitors to mTOR inhibitors as primary immunosuppressive drugs in pediatric heart transplantation.","volume":"31","author":"Asante-Korang","year":"2017","journal-title":"Clin Transplant"},{"key":"R37-20250821","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/petr.12163","article-title":"Empiric switch from calcineurin inhibitor to sirolimus-based immunosuppression in pediatric heart transplantation recipients.","volume":"17","author":"Loar","year":"2013","journal-title":"Pediatr Transplant"},{"key":"R38-20250821","doi-asserted-by":"crossref","first-page":"v24","DOI":"10.1055\/s-0034-1394000","article-title":"Initial experience with CNI-free immunosuppression in pediatric heart transplant recipients - anticipating PTLD and chronic renal insufficiency.","volume":"62","author":"Schubert","year":"2014","journal-title":"Thorac Cardiovasc Surg"},{"key":"R39-20250821","article-title":"KDIGO 2023 clinical practice guideline for the evaluation and management of chronic kidney disease 2023 [cited 2024 April 22]."},{"key":"R40-20250821","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial.","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"key":"R41-20250821","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","article-title":"Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease.","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int"},{"key":"R42-20250821","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease.","volume":"99","year":"2021","journal-title":"Kidney Int"},{"key":"R43-20250821","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/kisup.2012.41","article-title":"Clinical practice guideline for anemia in chronic kidney disease: summary of recommendation statements.","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"R44-20250821","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1161\/CIR.0000000000000560","article-title":"Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association.","volume":"137","author":"Konstam","year":"2018","journal-title":"Circulation"},{"key":"R45-20250821","article-title":"KDIGO. Preventing AKI in Cardiac Surgery [cited 2024 April 22].","author":"Engelman"},{"key":"R46-20250821","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(23)00642-6","article-title":"Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial.","volume":"402","author":"Collins","year":"2023","journal-title":"Lancet"},{"key":"R47-20250821","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.healun.2010.01.005","article-title":"Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation.","volume":"29","author":"Gude","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R48-20250821","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.healun.2007.07.034","article-title":"Sirolimus-based immunosuppression after cardiac transplantation: predictors of recovery from calcineurin inhibitor-induced renal dysfunction.","volume":"26","author":"Gustafsson","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R49-20250821","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/ajt.13588","article-title":"Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: three-year results from the randomized SCHEDULE study.","volume":"16","author":"Andreassen","year":"2016","journal-title":"Am J Transplant"},{"key":"R50-20250821","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/TP.0000000000002702","article-title":"Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: long-term follow-up from the randomized SCHEDULE study.","volume":"104","author":"Gustafsson","year":"2020","journal-title":"Transplantation"},{"key":"R51-20250821","doi-asserted-by":"crossref","first-page":"e15251","DOI":"10.1111\/ctr.15251","article-title":"Utility of a fusion protein T-cell co-stimulation blocker Belatacept in heart transplant recipients: real world experience from a high volume center.","volume":"38","author":"Oren","year":"2024","journal-title":"Clin Transplant"},{"key":"R52-20250821","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.healun.2022.01.008","article-title":"The impact of induction therapy on mortality and treated rejection in cardiac transplantation: a retrospective study.","volume":"41","author":"Bellumkonda","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R53-20250821","doi-asserted-by":"crossref","first-page":"484","DOI":"10.12659\/AOT.904225","article-title":"Prolonged administration of twice-daily bolus intravenous tacrolimus in the early phase after lung transplantation.","volume":"22","author":"Hirano","year":"2017","journal-title":"Ann Transplant"},{"key":"R54-20250821","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.healun.2011.02.008","article-title":"Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.","volume":"30","author":"Alloway","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R55-20250821","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.transproceed.2019.04.028","article-title":"Conversion from immediate-release tacrolimus to prolonged-release tacrolimus in stable heart transplant patients: a retrospective study.","volume":"51","author":"Gonz\u00e1lez-V\u00edlchez","year":"2019","journal-title":"Transplant Proc"},{"key":"R56-20250821","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ehf2.12585","article-title":"Incidence of end-stage renal disease after heart transplantation and effect of its treatment on survival.","volume":"7","author":"Roest","year":"2020","journal-title":"ESC Heart Fail"},{"key":"R57-20250821","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1111\/j.1600-6143.2010.03292.x","article-title":"Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients.","volume":"10","author":"Cassuto","year":"2010","journal-title":"Am J Transplant"},{"key":"R58-20250821","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.healun.2016.08.004","article-title":"Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation.","volume":"36","author":"Grupper","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R59-20250821","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation.","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"R60-20250821","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-6143.2006.01640.x","article-title":"The outcome of heart transplant recipients following the development of end-stage renal disease: analysis of the Canadian Organ Replacement Register (CORR).","volume":"7","author":"Alam","year":"2007","journal-title":"Am J Transplant"},{"key":"R61-20250821","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1681\/ASN.2014111111","article-title":"Prevalence, predictors, and outcomes of pulmonary hypertension in CKD.","volume":"27","author":"Navaneethan","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R62-20250821","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/TP.0b013e31828dbbbe","article-title":"Do echocardiographic parameters predict mortality in patients with end-stage renal disease?","volume":"95","author":"Stallworthy","year":"2013","journal-title":"Transplantation"},{"key":"R63-20250821","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/MOT.0000000000000942","article-title":"Cardiovascular risk stratification in the noncardiac solid organ transplant candidate.","volume":"27","author":"Truby","year":"2022","journal-title":"Curr Opin Organ Transplant"},{"key":"R64-20250821","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIR.0b013e31823eb07a","article-title":"Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation.","volume":"126","author":"Lentine","year":"2012","journal-title":"Circulation"},{"key":"R65-20250821","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/TP.0000000000001043","article-title":"Evaluation and management of pulmonary hypertension in kidney transplant candidates and recipients: concepts and controversies.","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T14:06:55Z","timestamp":1755785215000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005302","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]}}}